7255-3822 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

7255-3822 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide
7255-3822 Screening compound: N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 7255-3822
N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7255-3822

Molecular Formula

C18H12BrN3O3S (C18 H12 BrN3 O3 S)

Compound Name

N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-(2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)acetamide

IUPAC name

N-[4-(4-bromophenyl)-13-thiazol-2-yl]-2-(2-oxo-23-dihydro-13-benzoxazol-3-yl)acetamide

SMILES

O=C(CN(c(cccc1)c1O1)C1=O)Nc1nc(-c(cc2)ccc2Br)cs1

InChI

InChI=1S/C18H12BrN3O3S/c19-12-7-5-11(6-8-12)13-10-26-17(20-13)21-16(23)9-22-14-3-1-2-4-15(14)25-18(22)24/h1-8,10H,9H2,(H,20,21,23)

InChI Key

LJUKPQRQLPAARU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05999007

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.28

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.956

Distribution Coefficient, logD

4.956

Water Solubility, LogSw

-4.92

Polar Surface Area

55.991

Acid Dissociation Constant (pKa)

11.81

Base Dissociation Constant (pKb)

-2.09

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

5.60

7255-3822 in Drug Discovery

Included in Screening Libraries

Dark Chemical Matter Library (18430 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

SmartTM Library (51161 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Structure:
  • Pool
Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 7255-3822 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7255-3822?
Check Price and Availability of 7255-3822, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7255-3822 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7255-3822
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7255-3822
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7255-3822 available by request